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Background: This study aimed to evaluate the role of acanthosis nigricans (AN) as a marker of Type 2 Diabetes
Mellitus (T2DM) by studying its prevalence and relationship with age, ethnicity, anthropometry and other risk
factors for T2DM in the Trinidadian population.
Methods: 311 successive adult patients with T2DM were recruited at diabetic clinics and inpatient wards across
Trinidad. The presence, severity and texture of AN at the neck were assessed. Demographic, clinical and
anthropometric characteristics were also measured, and logistic regression was used to model their relationship
with presence of AN.
Results: The mean (SD) age was 58.1 years (12.6). 55.6% were female. 61.1% were East Indian, 24.4% African and
14.5% mixed ethnicity. The mean (SD) BMI was 27.3 kg/m2 (6.0) and the mean (SD) waist circumference was
96.7 cm (14.2). Prevalence of AN was 52.7% (95% CI 47.2, 58.3).
There was a greater odds of AN among diabetic patients who were: younger (p < 0.001); female (OR 1.67; 95% CI
1.06, 2.62); or East Indian rather than African (0.45; 0.26, 0.77) or mixed (0.43; 0.22, 0.84) descendents. There was a
greater age-, sex- and ethnicity-adjusted odds of AN among those: overweight (3.98; 2.10, 7.55) or obese (8.31; 3.84,
18.00) versus normal BMI; centrally obese (4.72; 2.65, 8.43); with history of hypertension (2.19; 1.27, 3.79) or history of
hypercholesterolemia (1.72; 1.02, 2.90), but there was no evidence of this demographic-adjusted association (p > 0.4)
between AN and history of previous MI or CVA, family history of T2DM, T2DM treatment regimen, duration of T2DM
or random blood glucose.
On further multivariable analysis, only age, sex, ethnicity, BMI and waist circumference were independently
associated with AN (p < 0.05) and the effect of BMI varied with ethnicity.
Conclusions: There was a high prevalence of AN both overall and across age, sex and ethnic groups of diabetic
patients. AN exhibited much potential as a valuable addition to T2DM risk assessment in the Trinidadian and similar
settings.
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Trinidad and Tobago is a twin-island unitary republican
state in the Southern Caribbean with a population of 1.3
million inhabitants derived mostly of descendants from
peoples of India (35%) and West Africa (34%) with a
sprinkling of others of Chinese, Syrian/Lebanese and
Caucasoid stock. Arising out of this background is
an expanding group of mixed ethnicity who currently
accounts for approximately 23% of the population [1].
As early as the 1960’s, a national survey of more than
20,000 individuals revealed an adult prevalence of Type
2 diabetes mellitus (T2DM) of 3.5%, already one of the
highest in the Hemisphere, and identified a higher preva-
lence among Indian descendants [2]. Twenty years later,
the St James Survey, a longitudinal study in an urban set-
ting, confirmed this persistently increased risk for diabetes
among East Indians, about twice that for Africans. Interest-
ingly people of mixed ancestry were identified in that study
to exhibit low risk for both diabetes and its associated
complication, ischaemic heart disease [3].
More recently data from the Trinidad and Tobago
Chronic Non-Communicable Disease Risk Factor (Pan
American STEPS) Survey showed a prevalence of T2DM
of 20% among individuals between 15–64 years of age
[4]. Against this background, it is therefore not surprising
that T2DM and its complications account for considerable
use of resources, bed space and clinical load [5].
Given this burden of disease, clinicians require sensi-
tive, safe and inexpensive screening tests so that inter-
ventions can be instituted earlier. In some populations,
acanthosis nigricans (AN) has been recommended as a
suitable tool for such screening [6], as its association
with T2DM, insulin resistance and obesity is well-
established [7,8]. However, studies have reported that
the prevalence of AN varies greatly in different ethnic
groups [9] and any recommendation for its use must be
relevant to the population for which this is intended.
Thus Grandhe et al. report that up to two-thirds of type
2 diabetic patients from North India will display this
sign [10] whereas a study from Nigeria showed that less
than 20% will so do [11]. In general, darker races are
more likely to exhibit this sign than are Whites [9].
This study aimed to evaluate the role of AN as a
marker of T2DM by studying its prevalence and rela-
tionship with age, ethnicity, anthropometry and other risk
factors for T2DM in the Trinidadian population.
Methods
This is a cross-sectional study. Three hundred and eleven
(311) successive subjects were recruited at dedicated dia-
betic outpatient clinics and the general medical and surgi-
cal inpatient wards at the Port of Spain General Hospital,
San Fernando General Hospital and Eric Williams Medical
Sciences Complex in Trinidad. These hospitals are thethree main public hospitals and together serve a national
population of 1.3 million. Approval was obtained from
the ethics committees of participating hospitals and of
the University of the West Indies, and research was in
compliance with the Helsinki Declaration.
Included in this study were individuals 18 years of age
and older with T2DM (according to the World Health
Organisation (WHO) definition [12]) and who were able
to give informed consent. Patients were excluded if they
had other endocrine or systemic diseases known to
result in AN. More specifically, patients with a history
of, being investigated for, or diagnosed with one or
more of the following were excluded: internal malig-
nancy (gastrointestinal); autoimmune conditions such as
systemic lupus erythematosus, scleroderma, Sjogren’s syn-
drome and Hashimoto’s thyroiditis. Also excluded from
the study were subjects with a history of intake of drugs
which can cause AN (nicotinic acid, oral contraceptives,
topical fusidic acid, methyltestosterone and triazinate) [8,9]
as well as subjects who were unable to give a cohesive his-
tory, had a high alcohol intake (>14 units/week for women
and >21 units/week for men), used illicit drugs, were less
than 18 years of age or who did not have T2DM.
The main outcome measure was AN. Subjects were
examined for the presence of AN at the neck, and its se-
verity and texture were graded using standard scales as
described by Burke et al. [13]. Severity was graded from
0 to 4 as follows: grade 0 - not visible on close inspec-
tion; grade 1 - clearly present on close visual inspection;
grade 2 - limited to base of the skull but does not extend
to the lateral margins of the neck; grade 3 - extending to
the lateral margins of the neck but not visible from the
front; and grade 4: extending to the anterior neck. The
texture of AN at the neck was graded from 0 to 3 as fol-
lows: Grade 0 - smooth to touch, no differentiation from
normal skin to palpation; Grade 1- rough to touch, clearly
differentiated from normal skin; Grade 2 - coarseness can
be observed visually, portions of the skin clearly raised
above other areas; and Grade 3 - extremely coarse, “hills
and valleys” observable on visual examination. The pres-
ence of AN at other typical sites, including knuckles,
elbows, axillae and knees, was also documented. Those
patients with localized hyperpigmentation without skin
thickening were not considered to have AN [13]. AN was
assessed by a single trained observer.
Demographic and clinical characteristics, including
anthropometric measurements, were also taken. An
administered questionnaire was used to collect data on:
age; sex; self-reported ethnicity; previous history of
hypercholesterolemia, hypertension, myocardial infarction
(MI) and/or cerebrovascular accident (CVA); family history
of T2DM; duration of T2DM; and treatment with oral
hypoglycaemics, insulin or both. The absence of the exclu-
sion criteria mentioned previously was also ascertained.
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obtained from medical records as a surrogate for blood
glucose control in the absence of consistently available
HbA1c. Anthropometric measurements taken included the
weight and height of all subjects. These were measured
according to usual clinical practice, and body mass index
(BMI) was calculated as weight in kilograms divided by
height in metres squared. Waist circumference was mea-
sured midway between the lower margin of the ribcage
and the superior rim of the ilium using a flexible tape
measure.
Statistical analysis
Data were analysed using Stata Version 13.0. All statistical
tests were interpreted at the 5% level of significance. Popu-
lation characteristics were summarised. The distribution of
AN both overall and by each population characteristic was
examined. The effect of each explanatory variable on the
odds of AN was summarised using odds ratios (ORs) with
95% confidence intervals (CIs) that were adjusted for the
confounding effect of demographic characteristics of age,
sex and ethnicity in a logistic regression model. The likeli-
hood ratio test (LRT) was used to test the age-, sex- and
ethnicity-adjusted association between AN and each
explanatory variable. Age, BMI and waist circumference
were categorised using clinically relevant cut-points for
data summary, measures of effect and hypothesis testing.
Age was adjusted for in continuous form.
Multivariable logistic regression modelling was used to
further explore confounding by other explanatory vari-
ables. All measured variables were included in the initial
model and backward elimination of terms was per-
formed: terms with the largest p values on the Wald test
were eliminated stepwise until all terms had p < 0.05.
Subsequently, interactions of all retained terms with
age, sex and ethnicity were investigated and retained
if p < 0.05. All continuous variables were modelled in
original form. This final model determined was later
refitted with BMI in categorical form to further explore
and interpret the interaction detected.
Characteristics found to be independently associated
with the presence AN were further evaluated for a
simple linear trend with increasing severity of AN – for
descriptive interest. The chi-squared test for trend was
used to evaluate evidence of a trend in the proportion of
participants with a binary characteristic across increasing
grades of AN severity; each ethnic group was treated as
a binary characteristic. The ANOVA trend test was used
to assess linear trends in the mean of continuous vari-
ables across increasing severity of AN. Regression coeffi-
cients were subsequently evaluated and tested in linear
and logistic regression models for continuous and categor-
ical variables respectively. The Cuzick [14] nonparametric
extension of the Wilcoxon rank-sum test [14] was used totest for a trend in the average texture of AN across increas-
ing grade of AN severity.
An estimated sample size of 272 participants was re-
quired to estimate the prevalence of AN among patients
with T2DM with a total confidence interval width of
0.10, confidence level of 90%, and an expected propor-
tion of AN of 0.50. The estimated prevalence of AN in
T2DM varied widely in the literature from 36% in one
study of a diverse ethnic population [15] to 63% in a
population of North Indians [10]. An expected propor-
tion of AN of 0.5 therefore chosen since it corresponded
to the largest estimated sample size.
Results
Sample characteristics
The study sample comprised 311 patients with T2DM.
Their demographic and clinical characteristics are sum-
marised in Table 1. Their mean age was 58.1 years
(SD 12.6; range 25–99 years). 55.6% were female. 61.1%
were East Indian, 24.4% African and 14.5% mixed ethnicity.
The mean BMI was 27.3 kg/m2 (SD 6.0) and the mean
waist circumference was 96.7 cm (SD 14.2).
Prevalence of AN
The prevalence of AN among all study participants was
52.7% (95% CI 47.2, 58.3). Table 1 shows the estimated
prevalence of AN in different subgroups. Of note, 58.4%
of females compared to 45.7% of males had AN. The
prevalence of AN decreased from 75.0% in the youngest
age group (25–39 years) to 33.9% in the oldest age group
(≥70 years). 60.5% of participants of East Indian descent
had AN as compared to 40.8% and 40.0% of participants of
Africans and mixed descent respectively. The prevalence of
AN among normal-BMI participants was 30.2% as com-
pared to 61.7% and 76.8% among overweight and obese
participants respectively and 68.3% of those with central
obesity had AN compared to 36.5% of those without.
Age-, sex- and ethnicity-adjusted associations with AN
Table 1 further compares the prevalence (via odds ratios)
of AN in different demographic and clinical subgroups.
There was a greater odds of AN among those who were:
younger (p < 0.001); female (OR 1.67; 95% CI 1.06, 2.62)
and of East Indian descent rather than of African (OR
0.45; 95% CI 0.26, 0.77) or mixed (OR 0.43; 95% CI 0.22,
0.84) descent. After adjusting for the confounding effect
of demographic features, there was a greater age- sex-
and ethnicity-adjusted odds of AN among those who
were: overweight (OR 3.98; 95% CI 2.10, 7.55) or obese
(OR 8.31; 95% CI 3.84, 18.00) compared to participants
of normal BMI; had central obesity (OR 4.72; 95% CI
2.65, 8.43); had a history of hypertension (OR 2.19; 95%
CI 1.27, 3.79) or a history of hypercholesterolemia (OR
1.72; 95% CI 1.02, 2.90).
Table 1 Acanthosis Nigricans (AN): prevalence, and age-, sex- and ethnicity-adjusted associations with demographic
and clinical characteristics
Characteristic Subgroup Overall frequency of
characteristic
Prevalence of AN in
subgroup
Age*-, sex- & ethnicity-adjusted
N (%) N (%) OR (95% CI)† p value‡
Age (years)† 25 - 39 28 (9.0) 21 (75.0) 5.84 (2.11, 16.18)
40 - 49 42 (13.5) 30 (71.4) 4.87 (2.04, 11.60)
50 - 59 94 (30.2) 56 (59.6) 2.87 (1.44, 5.72)
60 - 69 91 (29.3) 38 (41.8) 1.40 (0.70, 2.79)
≥70 56 (18.0) 19 (33.9) 1 <0.001
All [mean(SD)] [58.1 (12.6)]
Sex† Males 138 (44.4) 63 (45.7) 1
Females 173 (55.6) 101 (58.4) 1.67 (1.06, 2.62) 0.026
Ethnicity† East Indian 190 (61.1) 115 (60.5) 1
African 76 (24.4) 31 (40.8) 0.45 (0.26, 0.77)
Mixed 45 (14.5) 18 (40.0) 0.43 (0.22, 0.84) 0.003
Body Mass Index Underweight 6 (2.2) 0 (0.0)
(kg/m2)§, ¶ Normal 106 (38.5) 32 (30.2) 1
Overweight 94 (34.2) 58 (61.7) 3.98 (2.10, 7.55)
Obese 69 (25.1) 53 (76.8) 8.31 (3.84, 18.00) <0.001
All [mean(SD)] 27.3 (6.0)
Waist Circumference Normal 148 (50.5) 54 (36.5)
(cm)§, ** Central obesity 145 (49.5) 99 (68.3) 4.72 (2.65, 8.43) <0.001
All [mean(SD)] 96.7 (14.2)
Hypertension No 104 (33.4) 49 (47.1) 1
Yes 207 (66.6) 115 (55.6) 2.19 (1.27, 3.79) 0.004
Hypercholesterolemia No 121 (38.9) 56 (46.3) 1
Yes 190 (61.1) 108 (56.8) 1.72 (1.02, 2.90) 0.040
Family history of T2DM§ No 54 (17.4) 22 (40.7) 1
Yes 256 (82.6) 141 (55.1) 1.3 (0.68, 2.48) 0.420
CVA or MI No 233 (74.9) 122 (52.4) 1
Yes 78 (25.1) 42 (53.8) 1.26 (0.72, 2.22) 0.413
Diabetes Treatment Oral 192 (61.7) 101 (52.6)
Oral & Insulin 28 (9.0) 11 (39.3) 0.63 (0.26, 1.54)
Insulin 91 (29.3) 52 (57.1) 1.14 (0.67, 1.96) 0.467
RBG (mg/dL)§ All [med(IQR)] [145 (84)] 1.00 (0.998, 1.004) 0.584
Duration of T2DM (yrs)§ All [med(IQR)] [10 (16)] 1.00 (0.98, 1.03) 0.847
Overall 311 (100) 164 (52.7)
Abbreviations: AN Acanthosis Nigricans, OR Odds Ratio, CI Confidence Interval, SD Standard Deviation, BMI Body Mass Index, T2DM Type 2 Diabetes Mellitus, CVA
Cerebrovascular accident, MI Myocardial Infarction, RBG Random Blood Glucose, med median, IQR Inter-quartile range. *age adjusted for as a continuous variable;
†Odds Ratios for variables age, sex and ethnicity are univariable analyses; ‡p value for age-, sex- and ethnicity-adjusted association with AN from likelihood ratio
test; §36, 18, 1, 14, 1 missing observations for BMI, waist circumference, family history of T2DM, RBS and duration of T2DM respectively. No missing observations for other
variables. ¶ BMI (kg/m2): Underweight: <18.50; Normal: 18.50-24.99; Overweight: 25.00-29.99; Obese ≥30.00 [16]. **Central Obesity: waist circumference >102 cm in men
and >88 cm in women [17].
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ethnicity- adjusted association between AN and a history
of previous MI or CVA, a family history of T2DM,
T2DM treatment regimen, the duration of T2DM or the
RBG (Table 1).Multivariable analysis
Backward elimination of variables was performed, and
apart from the demographic characteristics of age,
sex and ethnicity, only BMI and waist circumference
remained significantly associated with AN (p < 0.05).
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no longer associated with AN after also adjusting for
the effect of anthropometry. Remaining characteristics,
which were not found to be associated with AN in pre-
vious analysis, remained that way and were eliminated
from the model. Further investigation for interactions
showed that the effect of BMI varied by ethnicity.
There was no evidence of an interaction (p > 0.05) of
any of the other variables in the model with either age,
sex or ethnicity.
This final multivariable model is shown in Table 2.
Holding other variables in the model constant, females
had a 2.33 greater odds of AN than males (95% CI 1.27 -
4.27). A 10 year decrease in age and 10 cm increase in
waist circumference was associated with a 1.87 (95% CI
1.41 - 2.48) and 1.40 (95% CI 0.99 - 1.99) greater odds of
AN respectively. Among East Indians, overweight and
obese diabetic patients had a 5.51 (95% CI 2.34 - 12.98)
and 12.27 (95% CI 2.79 - 53.97) greater adjusted odds of
AN respectively. However, among Africans and mixed par-
























*OR: Odds Ratio of AN adjusted for other variables in the model including age, sex,
OR; ‡p value from Wald test. §Parameter estimates from final multivariable model ¶P
illustrate the interaction between BMI and ethnicity. **Body Mass Index (BMI) (kg/m
Obese ≥30.00 [16].between BMI and AN. Among obese diabetic patients, East
Indians had a greater odds of AN than those of African
(OR 0.08; 95% CI 0.01 - 0.45) or mixed (OR 0.14; 95% CI
0.02 - 0.79) descent. In contrast, among normal-weight
diabetic patients there was no evidence that the adjusted
odds of AN in different ethnic groups was different; it was
noted, however, that normal-weight Africans had a 1.7
times greater adjusted odds of AN than normal-weight
East Indians, but there was insufficient evidence that this
association was not due to chance (p = 0.363).
Severity and texture of AN
The severity and texture of AN were graded separately.
Table 3 summarises the proportion of participants with
AN (n = 164) that fell into each of four categories of
increasing severity of AN. In general, fewer diabetic pa-
tients had a more severe grade of AN: 39.6% were grade
1 compared to 11.6% who were graded as most severe
(Grade 4). Participants with AN also fell into one of
three grades of increasingly rougher texture. The texture
of most AN was grade 1 (83.5%), 12.2% were grade 2tly associated with presence of Acanthosis Nigricans (AN)
OR* (95% CI†) p value‡
0.94 (0.91, 0.97) <0.001
es 1
ales 2.33 (1.27, 4.27) 0.006
Indian 1
an 1.70 (0.54, 5.33) 0.363
d 0.68 (0.18, 2.53) 0.570
Indian 1
an 0.11 (0.03, 0.41) 0.001
d 0.44 (0.10, 1.83) 0.258
Indian 1
an 0.08 (0.01, 0.45) 0.004
d 0.14 (0.02, 0.79) 0.027
al BMI** 1
rweight** 5.51 (2.34, 12.98) <0.001
se** 12.27 (2.79, 53.97) 0.001
al BMI** 1
rweight** 0.35 (0.08, 1.64) 0.183
se** 0.59 (0.11, 3.12) 0.534
al BMI** 1
rweight** 3.51 (0.60, 20.45) 0.162
se** 2.44 (0.37, 16.06) 0.352
1.03 (1.00, 1.07) 0.060
ethnicity, BMI and waist circumference; †CI: Confidence Interval for adjusted
arameter estimates from final model refitted with BMI as categorical, to
2): Underweight: <18.50; Normal: 18.50-24.99; Overweight: 25.00-29.99;
Table 3 Variation in the texture and presence of Acanthosis Nigricans (AN) at other sites by its severity
Severity of AN at the neck Texture of AN at the neck:
average grade (SD)
Proportion with AN at other sites*
N (%) N (%)
Grade 0 (not present) 146 - 15 (10.3)
Grade I 65 (39.6) 1.00 (0) 35 (53.9)
Grade II 37 (22.6) 1.11 (0.31) 25 (67.6)
Grade III 43 (26.2) 1.28 (0.45) 28 (65.1)
Grade IV 19 (11.6) 1.95 (0.91) 19 (100.0)
Grades I - IV 164 (100) 1.21 (0.50) 122 (39.4)
*One missing value for the presence of AN at other sites of the body.
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Table 3 summarises the average texture of AN among
participants with each grade of AN severity. More severe
AN of the neck was associated with a rougher texture of
AN of the neck (p < 0.001).
Linear trends by severity of AN
Characteristics associated with the presence of AN were
re-evaluated for a linear trend with increasing severity of
AN. It was found that each grade increase in severity of
AN was associated linearly with a 2.8 year decrease in
age (p = 0.001), 1.8 kg/m2 increase in BMI (p < 0.001), a
4.5 cm increase in waist circumference (p < 0.001), a
1.46 times greater odds of being of East Indian descent
(95% CI 1.04, 2.06; p = 0.028) and a 0.65 times lower
odds of being of African descent (95% CI 0.43, 0.98;
p = 0.041). For mixed participants, there was no evi-
dence of a linear trend (OR 0.85; 95% CI 0.53, 1.38;
p = 0.515) but the proportion of mixed participants
did vary by AN severity (p = 0.045). The proportion
of: females, those with a history of hypertension and
those with a history of hypercholesterolemia did not
vary by severity of AN (p > 0.70) even though persons with
these characteristics were overall more likely to have AN
(as seen previously).
AN at other sites of the body
Among all study participants, 107 (34.5%) had AN both
at the neck and at other sites, 15 (4.8%) had AN at other
sites only, 57 (18.4%) had AN at the neck only and the
remaining 131 (42.3%) did not have AN (one missing
value for AN at other sites). Therefore, AN was docu-
mented at other sites of the body (axillae, elbows, knuckles
and/or knees) in 122 (39.4%) participants. Compared to
those with AN at the neck, those without AN at the neck
had a much lower odds (OR 0.06; 95% CI 0.03, 0.11) of
manifesting AN at other sites. As illustrated in Table 3,
there was evidence that increasing severity of AN at the
neck, was associated with an increasing proportion of
diabetic patients with AN at other sites (p = 0.001). Only 3
participants (1.0%) had previously heard of AN.Discussion
In Trinidad, screening for T2DM is opportunistic: in
clinical settings, individuals are assessed for identifiable
risk factors and those subjectively deemed high-risk are
recommended for formal screening [18]. Currently, how-
ever, more than 50% of diabetic patients remain undiag-
nosed [18] and among those within reach of opportunistic
screening, a major contributor to non-detection is the
non-exhaustive collection of risk factors used to determine
risk – it can exclude diabetic patients in whom traditional
risk assessment is less convincing.
To address this issue, adjuncts to the current set of
risk factors are needed but they must be carefully
selected. New adjuncts should be not only sensitive, but
should improve the sensitivity of the already-in-use pool
of risk factors – they should broaden and strengthen the
definition of a high-risk individual. Since timely risk as-
sessment is vital in busy clinical settings, adjuncts must
be efficiently and safely implementable. Lastly, a specific
adjunct will limit the number of individuals wrongly
classified as high-risk. Here, we will explore the potential
of AN as an adjunct to T2DM risk assessment prior to
formal T2DM screening in the Trinidadian population.
We will explore the prevalence of AN among diabetic
patients, the potential of AN to improve detection of
T2DM and the innate qualities of the test that make it
suitable.
AN is “a symmetric eruption characterized by hyper-
pigmented, velvety cutaneous thickening that can occur
on any part of the body” [8]. It is considered a cutaneous
marker of hyperinsulinemia and insulin resistance [7,19]
and has been established as a risk factor for T2DM
[6,20,21]. AN has been formally recommended by the
ADA as part of the T2DM risk assessment criteria for
children and adolescents [22]. However, among adults, the
implementation of AN in this capacity has been limited by
infrequent manifestation in some populations [9].
In this Trinidad-based study, a relatively high mani-
festation of AN among diabetic patients was found - as
many as 1 in 2 diabetic patients had AN. Of note, AN
was 20% more likely to manifest in diabetic patients of
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to a higher prevalence of ectopic fat and associated insu-
lin resistance in the former [23]. However, the preva-
lence in all of these dominant ethnic groups was quite
high: 2 in 5 diabetic patients of either African or mixed
origin and 3 in 5 of East Indian origin demonstrated
AN. This high prevalence of AN - both overall and
among the major Trinidadian ethnic groups - strongly
supports its implementation as a sensitive marker of
T2DM in the unique ethnic population of Trinidad.
We also found the prevalence of AN to be high across
age groups although we did observe a steady decrease in
the prevalence of AN with increasing age. Formal rec-
ommendations of the American Diabetes Association
(ADA) have recognised AN as a risk factor for T2DM in
children and adolescents and have incorporated it into
formal risk assessment protocols since 2000 [6]. Studies
have found that approximately 60% to 92% of Black and
Hispanic children with T2DM have AN [19] making it a
highly sensitive marker in this age group. Indeed, in a
recent survey among asymptomatic school-aged children
screened for and confirmed with T2DM in Trinidad, all
had AN [24]. The current study provides additional evi-
dence of the value of AN as a valuable marker of T2DM
risk in younger age groups. However, despite decreasing
prevalence with age, more than one in three diabetic
patients in this study over 70 years had AN: AN was still
relatively prevalent in older age groups.
It is worth mentioning that this higher prevalence of
AN in younger diabetic patients was partially explained
by a higher prevalence of obesity in younger patients.
However, even after adjusting for BMI and other factors,
this trend of decreasing prevalence of AN with increas-
ing age was still clearly observed. Litonjua et al. observed
that newly diagnosed T2DM patients with AN “required
markedly higher insulin doses to achieve euglycaemia”
[15]. More severe insulin resistance in diabetic patients
with AN may explain this decreasing prevalence of AN
with age - a survivor effect.
The prevalence of AN was also high in both males
(46%) and females (58%). Polycystic ovary syndrome
(PCOS) is a well-established as an insulin-resistant state
[25,26] and may have accounted for some or all of the
higher prevalence of AN among women with T2DM.
To be a valuable adjunct to the T2DM screening
process, AN should improve risk assessment by trad-
itional risk factors. As recommended by the ADA, “the
decision to test for diabetes should ultimately be based
on clinical judgment and patient preference” [22]. Thus
as an established risk factor for T2DM that is highly
prevalent among diabetic patients in the Trinidadian
population, the observation of AN alongside other risk
factor(s) for T2DM should increase clinical suspicion
of T2DM. Additionally, the incidental or intentionalobservation of this well-established skin marker of in-
sulin resistance should prompt further risk assessment
for T2DM.
For example, in this study approximately 60% of dia-
betic patients were found to be obese or overweight, and
of these patients, 70% demonstrated AN. AN and obesity
are associated with greater insulin resistance than obes-
ity alone [27] and the finding of AN in an obese individ-
ual strengthens clinical suspicion of T2DM. Conversely,
approximately 40% of diabetic patients were found to be
of normal weight and as many as 30% of these dem-
onstrated AN i.e. 12% of all diabetic patients were of
normal weight yet manifested AN. AN in traditionally
low-risk groups may be a valuable indicator of T2DM.
However, in the absence of a control group in this study,
we were unable to quantify this effect.
The interaction between BMI and ethnicity revealed
interesting findings. Among obese diabetic patients, AN
was most prevalent among East Indians. Among diabetic
patients of normal weight however, Africans had a 1.7
times greater odds of demonstrating AN than East
Indians of the same age, sex and waist circumference.
Although the study was insufficiently powerful to show
that this OR was different from one, this unexpected
finding suggests that AN could be more prevalent among
African than East Indian diabetic patients of normal
weight, and this finding is worthy of further exploration
in appropriately-powered studies.
AN can be rapidly assessed at the neck making it an
extremely practical risk assessment tool. Examination
for AN at other sites of the body can also marginally
improve detection of T2DM. Among diabetic patients in
this study, 52.7% had AN at the neck with or without
AN at other sites, and a further 4.8% (approximately 1
in 20 diabetic patients) had AN only at other sites. Simi-
lar findings of neck involvement in 93% to 99% of AN
was noted in the literature [13,21]. The low sensitivity of
this further examination for AN at other sites, together
with the additional time demands that it incurs, may
render it impractical in routine practice. AN at other
sites has also been less extensively described and quanti-
fied than AN at the neck and this may affect the validity
of its routine assessment [13]. Potentially, the presence
of AN at other sites may still provide useful evidence of
T2DM risk in uncertain situations.
So far, we have discussed AN as a tool for improving
the detection of undiagnosed T2DM. However, AN is
also an important predictor of future T2DM. Stuart
et al. described it as “a readily visible marker of en-
dogenous hyperinsulinemia and thus, a marker for
risk of developing non-insulin-dependent diabetes” [20].
Therefore, like other established risk factors for T2DM,
the presence of AN is a valuable tool for recommenda-
tion of early lifestyle change for the prevention of T2DM
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is so readily manifest.
Apart from exploring AN as a valuable adjunct to
T2DM screening, its link to other cardiovascular risk
factors was explored. In this study, AN was found to
have a demographic-adjusted association with each of
obesity, hypertension and hypercholesterolemia. How-
ever, in our further multivariable analysis with all three
variables (as well as demographic variables), only obesity
remained associated with AN while the latter two did
not. Consistent with this, a strong association between
obesity, its accompanying insulin resistance, and AN is
widely documented [8,19], and these findings emphasize
that the presence of AN is more closely aligned with
obesity than other cardiovascular risk factors.
One limitation of this study was that it did not allow
for formal quantification of improvement in sensitivity
of T2DM risk assessment attributable to the addition of
AN to the pool of current risk factors. Such an assess-
ment would provide valuable evidence to support health
policy decision making. The promising results presented
here favour further research into quantifying the benefit
of AN in preparation for formal policy recommendation.
Another important limitation was that the study was
conducted in a population of diabetic patients only.
Therefore, the specificity of AN as a marker of T2DM
could not be assessed. Study findings suggest that AN is
a prevalent risk factor that can support clinical decision
making. However, lack of information on the specificity
of AN limits our ability to draw conclusions on whether
the presence of AN alone or in traditionally low-risk
groups is enough on its own to warrant screening for
T2DM. If AN were found to be relatively non-specific,
then its stand-alone value would be limited. Importantly,
however, AN also predicts future T2DM making any
measure of specificity difficult to interpret: while low
specificity may mean that fewer cases will truly have
T2DM, detection of AN provides an opportunity for
preventing or delaying future T2DM. Schwartz reported
that “it now appears that most, if not all, obesity-related
AN, as well as syndromic AN, is related to insulin-
resistant states” [8].
We also recognise that diabetic patients in our study
were sampled only from tertiary hospitals and our find-
ings may therefore be more representative of diabetic
patients with more severe disease. Since AN is associ-
ated with more severe disease [15], our estimate of
the prevalence of AN may be an over-estimation and
should be extrapolated to the general population of
diabetic patients with caution. Additionally, our infer-
ences concerning the usefulness of AN in detecting
undiagnosed T2DM, are based on the assumption that
the distribution of risk factors for T2DM in already-
diagnosed diabetic patients will be reflective of thatseen in undiagnosed patients, and this assumption may
not necessarily be true.
Conclusions
Among diabetic patients in Trinidad, AN is highly
prevalent both overall and across age, sex and ethnic
groups. The high prevalence of this established risk fac-
tor for T2DM, together with the simplicity and con-
venience of its assessment, support the implementation
of AN as a valuable addition to T2DM risk assessment
in Trinidad.
We recommend that AN should be proactively ob-
served in routine clinical practice in Trinidadian and
similar ethnic settings and that a finding of AN should
increase clinical suspicion of T2DM. Further study into
the specificity of AN is needed in order to understand
its value as a marker in traditionally low-risk groups.
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